thiazoles has been researched along with Bladder Cancer in 122 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 80 (65.57) | 18.7374 |
| 1990's | 7 (5.74) | 18.2507 |
| 2000's | 11 (9.02) | 29.6817 |
| 2010's | 14 (11.48) | 24.3611 |
| 2020's | 10 (8.20) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J; Sun, K; Wang, D; Wang, J; Wang, T; Wu, G; Wu, J | 1 |
| Drewa, T; Fekner, Z; Jundziłł, A; Kazimierski, Ł; Kloskowski, T; Krzeszowiak, K; Pokrywczyńska, M; Szeliski, K | 1 |
| Cho, YM; Heo, J; Hong, B; Jeong, EM; Jeong, SM; Ju, H; Kim, Y; Lee, J; Lee, S; Lim, J; Nam, YJ; Ryu, CM; Shin, DM; Son, J; Yun, H | 1 |
| Berg, M; Cinatl, J; Michaelis, M; Rothweiler, F; Stege, H; Vallo, S; Winkelmann, R | 1 |
| Dai, G; Jin, L; Liu, X; Shan, Y; Wang, L; Xiang, H; Xue, B; Yao, Q; Yuan, F | 1 |
| Assalin, HB; Ferrari, KL; Ikari, O; Kiehl, IGA; Ossick, MV; Reis, LO; Riccetto, E; Salustiano, ACC | 1 |
| Bittard, H; Elie-Caille, C; Fauconnet, S; Lascombe, I; Péchery, A | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Dai, Y; Deng, D; Jin, S; Li, G; Liu, Z; Shu, Q; Sun, H; Wang, S; Wu, S; Xiao, Z; Xie, L; Xu, M; Zhang, E; Zhang, S | 1 |
| Hu, J; Lei, Q; Li, Y; Ou, T; Sun, H; Wang, G; Wang, S; Wu, K; Wu, S; Yang, Z | 1 |
| Hodgkinson, L | 1 |
| Bourn, J; Cekanova, M | 1 |
| Arantes-Rodrigues, R; Colaço, A; Ferreira, R; Gaivão, I; Neuparth, MJ; Oliveira, P; Palmeira, C; Pinto-Leite, R; Pires, MJ; Santos, L | 1 |
| Han, G; Li, H; Li, T; Li, Y; Shi, LH; Wang, W | 1 |
| Barrios, CH; Battastini, AM; Bertola, G; Dietrich, F; Figueiró, F; Gerhardt, D; Moreira Fonseca, JC; Morrone, FB; Salbego, CG; Zanotto-Filho, A | 1 |
| Kubisch, R; Müller, R; Schempp, CM; Schreiner, L; Vollmar, AM; von Schwarzenberg, K; Wagner, E | 1 |
| Chang, LS; Chen, Y; Gao, Y; He, D; Lu, X; Shi, Q; Wang, X; Wu, K; Zeng, J; Zhang, L | 1 |
| Chen, YR; Efferth, T; Hamm, R; Müller, R; Seo, EJ; Wu, CF; Yang, NS; Zeino, M | 1 |
| Chen, J; Gao, JM; Gao, MT; Guo, LS; Li, CY; Li, HX; Liang, JQ; Wang, QL; Wu, YJ; Zhang, SY | 1 |
| Bittard, H; Fauconnet, S; Lascombe, I; Péchery, A | 1 |
| Jiang, G; Wang, J; Wang, L; Zeng, F; Zhu, Z | 1 |
| Chintharlapalli, S; Cho, SD; Inamoto, T; Kamat, AM; Papineni, S; Safe, S | 1 |
| Li, P; Lu, Q; Qing, W; Tao, J; Wu, D; Xu, B; Zhang, W | 1 |
| Jeong, YM; Kim, DS; Kim, MK; Kim, SY; Li, H | 1 |
| Czuba, ZP; Kawczyk-Krupka, A; Krol, W; Sieron, A; Sieron-Stoltny, K; Szliszka, E | 1 |
| Bommer, NX; Gunn-Moore, DA; Hayes, AM; Scase, TJ | 1 |
| Hanel, EG; Karmali, S; Kilani, RT; Mackey, J; Moore, RB; Tamimi, Y; Wong, KK | 1 |
| Georganas, C; Kosmaoglou, EV; Papatsoris, AG; Pardalidis, NP | 1 |
| Hase, T; Kawahito, Y; Matsuyama, M; Mitsuhashi, M; Nakatani, T; Sano, H; Segawa, Y; Tsuchida, K; Wada, S; Yoshimura, R | 1 |
| TRUINI, F | 1 |
| Chung, J; Jin, RJ; Kwak, C; Lee, CH; Lee, KH; Lee, SE | 1 |
| Davies, BR; Flecknell, PA; Roughan, JV | 1 |
| Jansen, CF; Schalken, JA; van der Heijden, AG; Verhaegh, G; Witjes, JA | 1 |
| Akaza, H; Hattori, K; Iida, K; Joraku, A; Oyasu, R; Tsukamoto, S | 1 |
| Eggenschwiler, J; Hunziker-Basler, N; Rist, L; Simões-Wüst, AP; Viviani, A; Zuzak, TJ | 1 |
| Babayan, RK; Carpinito, GA; Cohen, EB; Ho, ZS; Krane, RJ; Osband, ME | 1 |
| Davis, BB; Wise, RW; Zenser, TV | 2 |
| Hayashida, S; Wang, CY | 2 |
| Bolla, RI; Davis, BB; Mattammal, MB; Palmier, MO; Zenser, TV | 1 |
| Crabtree, WN; Matheny, RB; Murphy, WM; Soloway, MS | 1 |
| Cohen, SM; Davis, BB; Murasaki, G; Zenser, TV | 1 |
| Drago, JR | 1 |
| Cohen, SM; Fukushima, S; Hasegawa, R; Murasaki, G; St John, M | 1 |
| Bryan, GT; Swaminathan, S | 1 |
| Cohen, SM; Davis, BB; Fukushima, S; Mattammal, MB; Murasaki, G; Rapp, NS; Zenser, TV | 1 |
| Cohen, SM; Murasaki, G | 1 |
| Cohen, SM; Pauli, BU; Weinstein, RS | 1 |
| Arai, M; Cohen, SM; Friedell, GH; Fukushima, S; St John, M | 1 |
| Cohen, SM | 1 |
| Garner, CD; Hirose, M; Wang, CY | 1 |
| Croft, MA; Croft, WA; Lower, GM; Paulus, KP; Wang, CY; Williams, JH | 2 |
| Brugarolas, A; Gosálvez, M | 1 |
| Cohen, SM; Fukushima, S; Greenfield, RE; Murasaki, G | 1 |
| Mickey, DD; Mickey, GH; Murphy, WM; Niell, HB; Soloway, MS | 1 |
| Allhoff, EP; Chapman, CM; Hagen, IK; Lin, CW; Lin, JC; Mei, H; Proppe, KH; Prout, GR | 1 |
| Mickey, DD; Niell, HB; Soloway, MS; Wood, CA | 1 |
| Bryan, GT; Ertürk, E; Headley, DB; Klopp, RG; Michie, PM | 1 |
| Grossman, HB; Lesser, ML; Sonda, LP | 1 |
| Cohen, SM; Friedell, GH; Fukushima, S; Jacobs, JB | 1 |
| Rowland, RG; Wearly, DW | 1 |
| McCallum, LW; Nissenkorn, I; Soloway, MS | 1 |
| Crooke, ST; Daskal, Y; DeFuria, MD; Soloway, MS | 1 |
| Balin, VV; Pliss, GB; Vlasov, NN | 1 |
| Bryan, GT; Matsushima, M | 1 |
| Dos Santos, AV; Hussain, RF; Mansouri, M; Nouri, AM; Oliver, RT | 1 |
| Masters, JR; Osborne, EJ; Parris, CN; Walker, MC | 1 |
| Egawa, M; Hisazumi, H; Sasaki, T; Tanaka, M; Uchibayashi, T | 1 |
| Birch, BR; Cooper, AJ; Jennings, AM; Sharpe, P; Solomon, LZ | 1 |
| Banasiak, D; Barnetson, AR; Mameghan, H; Odell, RA; Russell, PJ | 1 |
| Breyer, MD; Breyer, RM; Davis, L; Guan, YF; Zhang, YH | 1 |
| Chlenski, A; Hattori, K; Hayashi, Y; Kita, A; Nakashiro, KI; Oyasu, R; Reddy, JK; Tamatani, T; Usuda, N | 1 |
| Bryan, GT; Cohen, SM; Headley, DB | 1 |
| Hyatt, CL; Javadpour, N; Soares, T | 1 |
| Arai, M; Brigham, SC; Jacobs, JB; Plotkin, GM; Wolf, G | 1 |
| Adolphs, HD; Kiel, H; Steffens, L; Thiele, J | 2 |
| Arai, M; Cohen, SM; Friedell, GH; Jacobs, JB | 3 |
| Cohen, SM; Friedell, GH | 1 |
| Bryan, GT; Cohen, SM | 1 |
| Alroy, J; Cohen, SM; Pauli, BU; Weinstein, RS | 1 |
| Hyatt, C; Marrone, JC; Martino, C; Soloway, MS | 1 |
| Alroy, J; Friedell, GH; Jacobs, JB; Merk, FB; Pauli, BU; Weinstein, RS | 1 |
| Matsushima, M | 1 |
| Murphy, GP; Williams, PD | 1 |
| Soloway, MS | 1 |
| Cohen, SM; Dekernion, JB; Persky, L; Soloway, MS | 1 |
| Schlegel, JU | 1 |
| Bryan, GT; Hayashida, S; Pamukcu, AM; Wang, CY | 1 |
| Bryan, GT; Cohen, SM; Wittenberg, JF | 1 |
| McMillan, TJ; Price, P | 1 |
| Cohen, SM; Hasegawa, R; Johansson, SL; Sakata, T | 1 |
| Nagakura, K; Nakamura, H; Odajima, K; Sawamura, M | 1 |
| Davis, BB; Rice, JR; Spry, LA; Zenser, TV | 1 |
| Anderström, C; Johansson, SL | 1 |
| Heckl, W; Jocham, K; Täuber, J; Vohr, HW | 1 |
| Asari, T; Hisazumi, H; Kobashi, K; Koshida, K; Naito, K; Uchibayashi, T | 1 |
| Cano, M; Cohen, SM; Ellwein, LB; Hasegawa, R; St John, M | 1 |
| Berger, MR; Habs, M; Petru, E; Schmähl, D | 1 |
| Cohen, SM; Hasegawa, R; Johansson, SL; Sakata, T; Zenser, TV | 1 |
| Davis, B; Lakshmi, VM; Spry, L; Zenser, T | 1 |
| Imaida, K; Wang, CY | 1 |
| Croft, WA; Hayashida, S; Kamiryo, Y; Wang, CY | 1 |
| Davis, BB; Rice, JR; Zenser, TV | 1 |
| Hosaka, Y; Matsushima, T; Muramatsu, M; Nagase, S; Niijima, T | 1 |
| Cohen, SM; Davis, BB; Spry, LA; Zenser, TV | 1 |
| Atassi, SA; Bryan, GT; Cohen, SM; Ertürk, E; Price, JM; Yoshida, O | 1 |
| Ahl, CA; Daly, JJ; Prout, GR | 2 |
| Del Vecchio, PR; Malmgren, RA; Marrone, JA; Myers, GH; Soloway, MS | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Lower, GM | 1 |
| Amaral, L; Pai, SH; Werthamer, S; Zak, FG | 2 |
| Tiltman, AJ | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E; Price, JM | 1 |
| Bryan, GT; Cohen, SM; Ertürk, E | 1 |
| Bryan, GT; Ertürk, E; Yoshida, O | 1 |
1 review(s) available for thiazoles and Bladder Cancer
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
3 trial(s) available for thiazoles and Bladder Cancer
| Article | Year |
|---|---|
Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors.
Topics: Acetanilides; Aged; BCG Vaccine; Cystectomy; Double-Blind Method; Female; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Thiazoles; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urological Agents | 2021 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Preliminary clinical results with norgamem (thioproline) and revercan (2-amino-2-thiazoline): the first inducers of reverse transformation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Clinical Trials as Topic; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms; Thiazoles; Thiazolidines; Urinary Bladder Neoplasms | 1982 |
119 other study(ies) available for thiazoles and Bladder Cancer
| Article | Year |
|---|---|
Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment.
Topics: Actins; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytoskeleton; Drug Screening Assays, Antitumor; Humans; Minerals; Resins, Plant; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms | 2021 |
The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Apoptosis; CDC2 Protein Kinase; Cell Proliferation; Cyclin-Dependent Kinases; Humans; Inhibitor of Differentiation Protein 2; Quinolines; Repressor Proteins; Thiazoles; Transcription Factors; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2022 |
Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.
Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cisplatin; Deoxycytidine; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Signal Transduction; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Urinary Bladder Neoplasms; Urothelium; X-Linked Inhibitor of Apoptosis Protein | 2020 |
Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells.
Topics: Acylation; AMP-Activated Protein Kinases; Autophagy; Autophagy-Related Protein-1 Homolog; Azo Compounds; beta-N-Acetylhexosaminidases; Cell Line, Tumor; Humans; Intracellular Signaling Peptides and Proteins; N-Acetylglucosaminyltransferases; Norleucine; Phosphorylation; Protein Processing, Post-Translational; Pyrans; RNA, Small Interfering; Thiazoles; Urinary Bladder Neoplasms | 2020 |
Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-guérin association.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Animals; BCG Vaccine; Drug Combinations; Female; Nitro Compounds; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder Neoplasms | 2021 |
Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
Topics: Antigens, CD; Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Microscopy, Atomic Force; PPAR delta; PPAR-beta; Signal Transduction; Thiazoles; Urinary Bladder Neoplasms | 2020 |
Transmucosal Delivery of Self-Assembling Photosensitizer-Nitazoxanide Nanocomplexes with Fluorinated Chitosan for Instillation-Based Photodynamic Therapy of Orthotopic Bladder Tumors.
Topics: Chitosan; Humans; Nitro Compounds; Photochemotherapy; Photosensitizing Agents; Thiazoles; Urinary Bladder Neoplasms | 2021 |
Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer.
Topics: Animals; Antineoplastic Agents; Antiparasitic Agents; Dose-Response Relationship, Drug; Female; HEK293 Cells; Humans; Lysosomes; Mice; Mice, Inbred BALB C; Mice, Nude; Mitophagy; Nitro Compounds; Reactive Oxygen Species; Thiazoles; Urinary Bladder Neoplasms | 2021 |
American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
Topics: Acetanilides; Administration, Intranasal; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials, Phase III as Topic; Deamino Arginine Vasopressin; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Hydrogels; Mitomycin; Multicenter Studies as Topic; Nocturia; Randomized Controlled Trials as Topic; Solifenacin Succinate; Thiazoles; United States; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urology | 2017 |
Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Axitinib; Benzamides; Caspases; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Humans; Imidazoles; Indazoles; Indomethacin; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-kit; Pyridines; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Thiazoles; Urinary Bladder Neoplasms | 2018 |
Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer.
Topics: Animals; Antineoplastic Agents; Butylhydroxybutylnitrosamine; Cell Cycle Checkpoints; Cell Proliferation; Comet Assay; Cyclooxygenase Inhibitors; DNA Damage; Flow Cytometry; Humans; Injections, Intraperitoneal; Male; Meloxicam; Mice; Mice, Inbred ICR; Microscopy; Neoplasms, Experimental; Precancerous Conditions; Thiazines; Thiazoles; Urinary Bladder Neoplasms | 2013 |
Expression and role of miR-34a in bladder cancer.
Topics: Adult; Aged; Apoptosis; Biomarkers, Tumor; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Middle Aged; Prognosis; Real-Time Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 2013 |
Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β.
Topics: Antineoplastic Agents; Apoptosis; Aporphines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Peumus; Plant Extracts; Proto-Oncogene Proteins c-akt; Rhodamines; Signal Transduction; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms | 2014 |
V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.
Topics: Animals; Anoikis; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms, Experimental; Macrolides; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Signal Transduction; Thiazoles; Urinary Bladder Neoplasms | 2014 |
Sinomenine reverses multidrug resistance in bladder cancer cells via P-glycoprotein-dependent and independent manners.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Coloring Agents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Indicators and Reagents; Morphinans; Real-Time Polymerase Chain Reaction; Rhodamine 123; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms | 2014 |
Induction of cholesterol biosynthesis by archazolid B in T24 bladder cancer cells.
Topics: Cell Line, Tumor; Cell Survival; Cholesterol; Drug Resistance, Neoplasm; Endocytosis; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lipoproteins, LDL; Macrolides; MicroRNAs; Real-Time Polymerase Chain Reaction; Receptors, LDL; Reproducibility of Results; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Thiazoles; Urinary Bladder Neoplasms | 2014 |
Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Drug Synergism; Female; Humans; Hypoglycemic Agents; Metformin; Signal Transduction; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Vitamins | 2015 |
Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
Topics: Apoptosis; Blotting, Western; Cell Proliferation; Flow Cytometry; Humans; Neoplasm Invasiveness; PPAR delta; PPAR-beta; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2016 |
Synthetic Smac peptide enhances chemo-sensitivity of bladder cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; Mitochondrial Proteins; Models, Biological; Peptides; Protein Structure, Tertiary; Tetrazolium Salts; Thiazoles; Time Factors; Urinary Bladder Neoplasms; X-Linked Inhibitor of Apoptosis Protein | 2008 |
1,1-Bis(3'-indolyl)-1-(p-chlorophenyl)methane activates the orphan nuclear receptor Nurr1 and inhibits bladder cancer growth.
Topics: Animals; Benzhydryl Compounds; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Humans; Indoles; Ligands; Male; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Nuclear Receptor Subfamily 4, Group A, Member 2; RNA Interference; Tetrazolium Salts; Thiazoles; Transcription Factors; Urinary Bladder Neoplasms | 2008 |
Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Chromones; Dose-Response Relationship, Drug; Doxorubicin; Humans; Inhibitory Concentration 50; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms | 2011 |
Arbutin inhibits TCCSUP human bladder cancer cell proliferation via up-regulation of p21.
Topics: Actins; Arbutin; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p21; Extracellular Signal-Regulated MAP Kinases; Gentian Violet; Humans; Neoplasm Proteins; Tetrazolium Salts; Thiazoles; Up-Regulation; Urinary Bladder Neoplasms | 2011 |
Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells.
Topics: Analysis of Variance; Annexin A5; Apoptosis; Cell Line, Tumor; Flow Cytometry; Humans; L-Lactate Dehydrogenase; Photochemotherapy; Porphyrins; Statistics, Nonparametric; Tetrazolium Salts; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Urinary Bladder Neoplasms | 2012 |
Clinical features, survival times and COX-1 and COX-2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam.
Topics: Animals; Carcinoma, Transitional Cell; Cat Diseases; Cats; Cyclooxygenase 1; Cyclooxygenase 2; Female; Immunochemistry; Isoenzymes; Male; Meloxicam; Neoplasm Proteins; Survival Analysis; Thiazines; Thiazoles; Urinary Bladder Neoplasms | 2012 |
Selective cytotoxicity of gemcitabine in bladder cancer cell lines.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Coculture Techniques; Coloring Agents; Deoxycytidine; Fibroblasts; Gemcitabine; Humans; Immunohistochemistry; Rats; Spheroids, Cellular; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 2002 |
Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer.
Topics: Acute Disease; Administration, Intravesical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Infectious; BCG Vaccine; Humans; Indomethacin; Male; Meloxicam; Middle Aged; Thiazines; Thiazoles; Treatment Outcome; Urinary Bladder Neoplasms | 2002 |
Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists.
Topics: Aged; Cell Division; Chromans; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Ligands; Male; Middle Aged; Neoplasm Staging; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Urinary Bladder; Urinary Bladder Neoplasms | 2003 |
[EVALUATION OF THE THERAPEUTIC EFFECTIVENESS OF 2-ACETAMIDO-4-(5-NITRO-2FURYL)-THIAZOLE. CLINICAL CASES].
Topics: Epididymitis; Humans; Male; Nitrofurans; Orchitis; Postoperative Complications; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Sepsis; Thiazoles; Thrombophlebitis; Urinary Bladder Neoplasms; Urinary Tract Infections | 1963 |
Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Death; Cell Line, Tumor; Cell Survival; Cisplatin; Clusterin; Coloring Agents; DNA Fragmentation; Glycoproteins; Humans; In Vitro Techniques; Molecular Chaperones; Oligonucleotides, Antisense; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Urinary Bladder Neoplasms | 2004 |
Behavioural assessment of the effects of tumour growth in rats and the influence of the analgesics carprofen and meloxicam.
Topics: Analysis of Variance; Animals; Behavior, Animal; Carbazoles; Disease Models, Animal; Male; Meloxicam; Pain; Pain Measurement; Pain, Postoperative; Rats; Rats, Inbred F344; Thiazines; Thiazoles; Urinary Bladder Neoplasms | 2004 |
Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Combined Modality Therapy; Deoxycytidine; Epirubicin; Gemcitabine; Humans; Hyperthermia, Induced; Indolequinones; Mitomycin; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms | 2005 |
Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cyclooxygenase Inhibitors; Gefitinib; Male; Meloxicam; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Inbred F344; Thiazines; Thiazoles; Treatment Outcome; Urinary Bladder Neoplasms | 2006 |
Prolonged cytotoxic effect of aqueous extracts from dried viscum album on bladder cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Plant Extracts; Tetrazolium Salts; Thiazoles; Urinary Bladder Neoplasms; Viscum | 2007 |
The relationship of histamine H2 receptor-bearing suppressor cells with the growth and metastasis of FANFT-induced bladder cancer.
Topics: Animals; Carcinoma, Transitional Cell; Cell Movement; FANFT; Female; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Phenotype; Receptors, Histamine; Receptors, Histamine H2; Spleen; T-Lymphocytes, Regulatory; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1983 |
Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT.
Topics: Animals; Benzidines; Carcinogens; Electron Spin Resonance Spectroscopy; FANFT; Free Radicals; Horseradish Peroxidase; Male; Microsomes; Prostaglandin-Endoperoxide Synthases; Seminal Vesicles; Sheep; Thiazoles; Urinary Bladder Neoplasms | 1983 |
Mutagenicity of urine of various species fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or 2-amino-4-(5-nitro-2-furyl)thiazole.
Topics: Animals; Biotransformation; Carcinogens; Cricetinae; FANFT; Female; Guinea Pigs; Mesocricetus; Mice; Mutagenicity Tests; Mutagens; Mutation; Nitrofurans; Rats; Rats, Inbred Strains; Salmonella typhimurium; Species Specificity; Thiazoles; Urinary Bladder Neoplasms; Urine | 1984 |
Peroxidase metabolism of the urinary bladder carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole.
Topics: Anaerobiosis; Animals; Benzidines; Carcinogens; Cattle; DNA; FANFT; Horseradish Peroxidase; Lactoperoxidase; Peroxidases; Prostaglandin-Endoperoxide Synthases; Thiazoles; Urinary Bladder Neoplasms | 1983 |
Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.
Topics: Animals; Carcinogens; DNA; FANFT; In Vitro Techniques; Oxidation-Reduction; Prostaglandin Endoperoxides; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Protein Binding; Proteins; Thiazoles; Urinary Bladder Neoplasms | 1983 |
Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats.
Topics: Animals; Caffeine; Carcinogens; Carcinoma, Transitional Cell; Cocarcinogenesis; FANFT; Female; Glucaric Acid; Glucuronidase; Nitroreductases; Oxidoreductases; Phenothiazines; Rats; Rats, Inbred F344; Sugar Acids; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
Metastatic characteristics of four FANFT-induced murine bladder tumors.
Topics: Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; FANFT; Lung Neoplasms; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Thiazoles; Urinary Bladder Neoplasms | 1983 |
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis.
Topics: Animals; Aspirin; FANFT; Male; Rats; Stomach Neoplasms; Thiazoles; Urinary Bladder Neoplasms | 1984 |
The Noble rat bladder cancer model. FANFT-induced tumors.
Topics: Animals; Cell Nucleus; Cyclophosphamide; Cytoplasm; Disease Models, Animal; FANFT; Female; Rats; Rats, Inbred Strains; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1984 |
Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat.
Topics: Animals; Aspirin; Carcinogens; Cell Division; Epithelium; FANFT; Male; Rats; Rats, Inbred F344; Stomach Neoplasms; Thiazoles; Urinary Bladder Neoplasms | 1984 |
Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice.
Topics: Animals; Biotransformation; Carbon Radioisotopes; FANFT; Female; Kinetics; Mass Spectrometry; Mice; Spectrophotometry; Thiazoles; Tissue Distribution; Urinary Bladder Neoplasms | 1984 |
Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
Topics: Animals; Aspirin; Biotransformation; Cyclooxygenase Inhibitors; FANFT; Hyperplasia; Male; Neoplasms, Experimental; Prostaglandins E; Rabbits; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Co-carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for the urinary bladder.
Topics: Animals; Cocarcinogenesis; Diet; FANFT; Growth; Male; Neoplasms, Experimental; Rats; Saccharin; Thiazoles; Tryptophan; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1983 |
Cellular changes in rat urinary bladder carcinomas induced by FANFT: a quantitative electron microscopic analysis.
Topics: Animals; Carcinogens; Cell Membrane; Cell Nucleus; Cytoplasm; Endoplasmic Reticulum; Epithelium; FANFT; Male; Microscopy, Electron; Neoplasms, Experimental; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1983 |
Long term dose response study of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced urinary bladder carcinogenesis.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; FANFT; Hyperplasia; Male; Neoplasms, Experimental; Papilloma; Prognosis; Rats; Rats, Inbred F344; Thiazoles; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1983 |
Promotion of urinary bladder carcinogenesis.
Topics: Animals; Carcinogens; FANFT; Mice; Neoplasms, Experimental; Organ Specificity; Thiazoles; Urinary Bladder Neoplasms; Urine | 1983 |
Effect of phenobarbital on the carcinogenesis of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Topics: Animals; Carcinogens; Drug Interactions; Drug Synergism; FANFT; Liver Neoplasms, Experimental; Male; Neoplasms, Experimental; Phenobarbital; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder Neoplasms | 1983 |
13-cis-retinoic acid: effect on urinary bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in Fischer rats.
Topics: Animals; Butylated Hydroxytoluene; Carcinogens; FANFT; Female; Isomerism; Isotretinoin; Neoplasms, Experimental; Rats; Rats, Inbred F344; Thiazoles; Tretinoin; Urinary Bladder Neoplasms | 1981 |
Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Topics: Animals; Cell Division; Cocarcinogenesis; Cyclophosphamide; FANFT; Hyperplasia; Male; Rats; Rats, Inbred F344; Regeneration; Saccharin; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors.
Topics: Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Line; FANFT; Karyotyping; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Thiazoles; Urinary Bladder Neoplasms | 1982 |
Rat bladder isograft model for focal carcinoma.
Topics: Animals; Carcinoma, Transitional Cell; FANFT; Methylnitrosourea; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Rats; Rats, Inbred Strains; Thiazoles; Transplantation, Isogeneic; Urinary Bladder Neoplasms | 1982 |
Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II).
Topics: Animals; Cell Line; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; FANFT; Female; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1982 |
Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs.
Topics: Animals; Antibody Formation; Carcinogens; Diet; FANFT; Female; Furans; Immunity, Cellular; Leukemia, Experimental; Lymphoid Tissue; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitrofurans; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1981 |
The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
Topics: Animals; Body Weight; Carcinoma, Papillary; Carcinoma, Transitional Cell; FANFT; Female; Hyperplasia; Methylnitrosourea; Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Topics: Animals; Carcinoma, Transitional Cell; Cocarcinogenesis; FANFT; Male; Neoplasms, Experimental; Rats; Saccharin; Thiazoles; Tryptophan; Urinary Bladder Neoplasms | 1981 |
Urinary diversion and systemic chemotherapy in the treatment of experimental early neoplastic lesions of the bladder.
Topics: Animals; Body Weight; Carcinogens; Carcinoma, Papillary; Cyclophosphamide; Male; Neoplasms, Experimental; Nitrofurans; Organ Size; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Diversion | 1981 |
Synthetic retinamides: effect on urinary bladder carcinogenesis by FANFT in Fischer rats.
Topics: Animals; Body Weight; FANFT; Female; Neoplasms, Experimental; Rats; Rats, Inbred F344; Thiazoles; Tretinoin; Urinary Bladder Neoplasms | 1981 |
Comparison between a purified and standard diet on FANFT-induced murine bladder cancer.
Topics: Animal Feed; Animals; Body Weight; Diet; FANFT; Female; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Organ Size; Thiazoles; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
Topics: Animals; Epithelium; FANFT; Female; Mice; Microscopy, Electron; Mitomycins; Neoplasms, Experimental; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1980 |
[Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
Topics: Animals; Carcinoma, Transitional Cell; FANFT; Formamides; Male; Neoplasms, Experimental; Papilloma; Rats; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1980 |
Early induction of mouse urinary bladder ornithine decarboxylase activity by rodent vesical carcinogens.
Topics: Adenosylmethionine Decarboxylase; Animals; Carboxy-Lyases; Carcinogens; Enzyme Induction; Epithelium; FANFT; Female; Mice; Neoplasms, Experimental; Ornithine Decarboxylase; Thiazoles; Tretinoin; Urinary Bladder; Urinary Bladder Neoplasms | 1980 |
Super-sensitive epithelial cell line and colorimetric assay to replace the conventional K562 target and chromium release assay for assessment of non-MHC-restricted cytotoxicity.
Topics: Cell Death; Colorimetry; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Epithelium; Female; Humans; Interferons; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Male; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs.
Topics: Antineoplastic Agents; Coloring Agents; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Male; Testicular Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1993 |
Comparative study of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and tritiated thymidine in a chemosensitivity test using collagen gel matrix.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Collagen; Coloring Agents; Drug Evaluation, Preclinical; Gels; Humans; Mice; Organ Culture Techniques; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Thymidine; Tritium; Urinary Bladder Neoplasms | 1993 |
Intravesical chemotherapy with gamma linolenic acid becomes a realistic prospect in serum-free applications: in vitro cytotoxicity and systemic absorption studies.
Topics: Administration, Intravesical; Animals; Carcinoma, Transitional Cell; Coloring Agents; Culture Media, Serum-Free; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Humans; Rats; Rats, Wistar; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1998 |
Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line.
Topics: Cell Survival; Dose-Response Relationship, Radiation; Humans; Radiation Tolerance; Rhodamines; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Stem Cell Assay; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1999 |
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins; Cell Death; Chromans; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; G1 Phase; Humans; Immunoblotting; In Situ Hybridization; Ligands; Luciferases; Myelin P2 Protein; Neoplasm Proteins; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Ribonucleases; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 1999 |
Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
Topics: Aged; Blotting, Western; Cell Division; Cell Line; Chromans; Dose-Response Relationship, Drug; Humans; Immunologic Factors; Ligands; Male; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transfection; Troglitazone; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Urothelium | 2001 |
Suppression of antibody-mediated and cell-mediated murine immunity by the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
Topics: Animals; Antibody-Producing Cells; Carcinogens; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Graft vs Host Reaction; Immunity; Immunity, Cellular; Immunosuppressive Agents; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitrofurans; Thiazoles; Urinary Bladder Neoplasms | 1977 |
Immunologic features of a carcinogen-induced murine bladder cancer: in vivo and in vitro studies.
Topics: Animals; Antigens, Neoplasm; Cross Reactions; Cytotoxicity, Immunologic; Epitopes; FANFT; Female; Fetus; Immunity; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Pregnancy; Thiazoles; Urinary Bladder Neoplasms | 1979 |
Uridine 5'-diphosphate galactose: glycoprotein galactosyl transferase activity in exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide.
Topics: Animals; beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase; Epithelial Cells; Epithelium; FANFT; Female; Galactosyltransferases; Humans; Hyperplasia; Male; Neoplasms, Experimental; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms; Urine | 1977 |
Biological behavior of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide induced carcinoma of the transitional epithelium in the rat.
Topics: Animals; Carcinoma, Transitional Cell; FANFT; Female; Kidney Neoplasms; Kidney Pelvis; Neoplasm Staging; Neoplasms, Experimental; Rats; Thiazoles; Urinary Bladder Neoplasms | 1978 |
Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Topics: Animals; Dose-Response Relationship, Drug; Epithelium; FANFT; Hyperplasia; Male; Microscopy, Electron, Scanning; Microvilli; Neoplasms, Experimental; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder Neoplasms | 1979 |
Carcinoma of the urinary bladder.
Topics: Animals; Carcinoma, Transitional Cell; Disease Models, Animal; FANFT; Humans; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder Neoplasms | 1979 |
Effect of p-hydroxyacetanilide, sodium sulfate, and L-methionine on the leukemogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
Topics: Acetanilides; Animals; Carcinogens; Drug Interactions; Female; Hydrazines; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Nitrofurans; Papilloma; Stomach Neoplasms; Sulfates; Thiazoles; Urinary Bladder Neoplasms | 1978 |
Induction of transitional cell carcinoma of the urinary bladder in rats by feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide. Histological and ultrastructural findings.
Topics: Animals; Carcinoma, Transitional Cell; Disease Models, Animal; Epithelium; FANFT; Female; Neoplasms, Experimental; Organ Size; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1978 |
Desmosome ultrastructure and biological behavior of chemical carcinogen-induced urinary bladder carcinomas.
Topics: Animals; Carcinoma, Transitional Cell; Cell Adhesion; Desmosomes; FANFT; Male; Microscopy, Electron; Neoplasm Invasiveness; Neoplasms, Experimental; Rats; Thiazoles; Urinary Bladder Neoplasms | 1978 |
Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
Topics: Animals; Antigens, Neoplasm; Carcinoma, Transitional Cell; Cross Reactions; FANFT; Female; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Thiazoles; Urinary Bladder Neoplasms | 1978 |
A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Topics: Animals; Epithelium; FANFT; Hyperplasia; Male; Microscopy, Electron, Scanning; Neoplasms, Experimental; Precancerous Conditions; Rats; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1977 |
Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
Topics: Animals; Cell Membrane; Cell Membrane Permeability; Cell Transformation, Neoplastic; Epithelium; FANFT; Humans; Intercellular Junctions; Male; Microscopy, Electron; Neoplasms, Experimental; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1977 |
[The role of L-tryptophan's promoting factor on tumorgenesis in the urinary bladder. 2. Urinary bladder carcinogenicity of FANFT (initiating factor) and L-tryptophan (promoting factor) in mice (author's transl)].
Topics: Animals; FANFT; Female; Mice; Neoplasms, Experimental; Thiazoles; Tryptophan; Urinary Bladder Neoplasms | 1977 |
Experimental bladder tumor induction, propagation, and therapy.
Topics: Administration, Oral; Animals; Carcinoma, Transitional Cell; FANFT; Female; Mice; Mice, Inbred C3H; Mitomycins; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Thiazoles; Urinary Bladder Neoplasms | 1976 |
FANFT-induced bladder tumors.
Topics: Animals; Disease Models, Animal; FANFT; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasms, Experimental; Thiazoles; Urinary Bladder Neoplasms | 1976 |
Light and scanning electron microscopy of exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Topics: Animals; Epithelial Cells; Epithelium; FANFT; Hyperplasia; Male; Microscopy, Electron, Scanning; Neoplasms, Experimental; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder Neoplasms; Urine | 1976 |
Failure of ascorbic acid to inhibit FANFT-induced bladder cancer.
Topics: Animals; Ascorbic Acid; Carcinogens; Carcinoma, Transitional Cell; Drug Evaluation; Formamides; Metaplasia; Mice; Mice, Inbred C3H; Nitrofurans; Precancerous Conditions; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1975 |
Letter: Re: failure of ascorbic acid to inhibit FANFT-induced bladder cancer.
Topics: Animals; Ascorbic Acid; Dogs; FANFT; Mice; Thiazoles; Urinary Bladder Neoplasms | 1976 |
Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Topics: Allopurinol; Animals; Carcinoma, Transitional Cell; Cytosol; Drug Synergism; FANFT; Female; Liver; Neoplasms, Experimental; Nitrate Reductases; Rats; Sulfhydryl Compounds; Thiazoles; Time Factors; Tryptophan; Urinary Bladder Neoplasms | 1976 |
Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
Topics: Animals; Body Weight; FANFT; Female; Metaplasia; Neoplasms, Experimental; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Vitamin A; Vitamin A Deficiency | 1976 |
Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation.
Topics: Carcinoma, Transitional Cell; Cell Division; Cell Survival; Humans; Neuroblastoma; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1990 |
Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Topics: Animals; Aspirin; FANFT; Kidney; Male; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1989 |
[Chemosensitivity testing on human bladder cancer cell lines, using MTT-assay].
Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Colorimetry; Drug Screening Assays, Antitumor; Humans; Hyperthermia, Induced; Predictive Value of Tests; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1989 |
Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
Topics: Acetylcysteine; Animals; Carcinogens; FANFT; Glutathione; Male; Methimazole; Peroxidases; Propylthiouracil; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Thiazoles; Urinary Bladder Neoplasms | 1988 |
The influence of antipyrene on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced urinary tract carcinogenesis.
Topics: Animals; Antipyrine; Cocarcinogenesis; FANFT; Kidney Neoplasms; Kidney Papillary Necrosis; Kidney Pelvis; Male; Rats; Rats, Inbred Strains; Thiazoles; Urinary Bladder Neoplasms | 1988 |
Identification of inhibitory growth factors from a N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder cancer cell line.
Topics: Animals; Carcinoma, Transitional Cell; Cell Line; Cell Transformation, Neoplastic; Chromatography, Gel; Chromatography, High Pressure Liquid; FANFT; Growth Substances; Mice; Peptides; Rats; Thiazoles; Transforming Growth Factors; Urinary Bladder Neoplasms | 1987 |
[Application of tetrazolium bromide to an in vitro chemosensitivity test].
Topics: Cell Division; Colony-Forming Units Assay; Humans; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1987 |
Effect of dose on the induction of urothelial proliferation by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and its relationship to bladder carcinogenesis in the rat.
Topics: Animals; Cell Division; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; FANFT; Male; Rats; Rats, Inbred F344; Thiazoles; Thymidine; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
Influence of the application mode of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide on the localization of its carcinogenic expression in female NMRI-mice.
Topics: Adenocarcinoma; Administration, Oral; Animals; Carcinoma, Squamous Cell; FANFT; Female; Mice; Mice, Inbred Strains; Papilloma; Stomach Neoplasms; Thiazoles; Urinary Bladder Neoplasms | 1986 |
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
Topics: Animals; Aspirin; Body Weight; Cocarcinogenesis; FANFT; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred F344; Saccharin; Thiazoles; Urinary Bladder Neoplasms | 1986 |
Metabolism and excretion of nitrofurothiazole bladder carcinogens.
Topics: Animals; FANFT; Glomerular Filtration Rate; Metabolic Clearance Rate; Protein Binding; Rats; Rats, Inbred Strains; Serum Albumin; Thiazoles; Tissue Distribution; Urinary Bladder Neoplasms | 1986 |
Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
Topics: Animals; Esophageal Neoplasms; FANFT; Hydrogen-Ion Concentration; Liver Neoplasms, Experimental; Male; Neoplasms, Experimental; Nitrosamines; Phenobarbital; Rats; Rats, Inbred F344; Saccharin; Stomach Neoplasms; Thiazoles; Thyroid Neoplasms; Urinary Bladder Neoplasms | 1986 |
Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats.
Topics: Animals; Body Weight; Carcinoma; Cocarcinogenesis; FANFT; Female; Hyperplasia; Kidney Pelvis; Rats; Rats, Inbred F344; Thiazoles; Uracil; Ureter; Urinary Bladder; Urinary Bladder Calculi; Urinary Bladder Neoplasms | 1987 |
Formation of thioether conjugates of the bladder carcinogen ANFT catalyzed by prostaglandin H synthase.
Topics: Chromatography, Liquid; Electrochemistry; Enzyme Activation; FANFT; In Vitro Techniques; Prostaglandin-Endoperoxide Synthases; Sulfides; Thiazoles; Urinary Bladder Neoplasms | 1985 |
Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Topics: Animals; FANFT; Hyperlipidemias; Male; Rats; Rats, Inbred Strains; Rats, Mutant Strains; Serum Albumin; Thiazoles; Urinary Bladder Neoplasms | 1985 |
Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.
Topics: Administration, Oral; Animals; Aspirin; Carcinoma; FANFT; Glomerular Filtration Rate; In Vitro Techniques; Kidney; Metabolic Clearance Rate; Probenecid; Rats; Rats, Inbred Strains; Thiazoles; Urinary Bladder Neoplasms | 1985 |
Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
Topics: Acetamides; Adenocarcinoma; Adenocarcinoma, Scirrhous; Adenofibroma; Animals; Carcinogens; Carcinoma, Transitional Cell; Dogs; Female; Formamides; Gallbladder; Gallbladder Neoplasms; Kidney Neoplasms; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrofurans; Thiazoles; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Urogenital System | 1970 |
Demonstration of specific antigen in N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide induced rat bladder tumor.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Culture Techniques; Cytotoxicity Tests, Immunologic; Female; Formamides; Histocompatibility Antigens; Immunodiffusion; Isoenzymes; Karyotyping; L-Lactate Dehydrogenase; Neoplasm Transplantation; Neoplasms, Experimental; Nitrofurans; Parabiosis; Rats; Thiazoles; Urinary Bladder Neoplasms | 1973 |
Immunological characteristics of experimental bladder cancer.
Topics: Animals; Formamides; Immunization, Passive; Neoplasm Transplantation; Nitrofurans; Rats; Thiazoles; Transplantation, Homologous; Urinary Bladder Neoplasms | 1972 |
Evaluation of urinary cytology as an indicator of bladder neoplasia in mice.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Erythrocytes; Female; Formamides; Hematuria; Mice; Neoplasms, Experimental; Nitrofurans; Thiazoles; Urinary Bladder Neoplasms; Urine | 1973 |
Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes.
Topics: Acetamides; Animals; Carcinogens; Carcinoma, Squamous Cell; Female; Formamides; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Papilloma; Stomach Neoplasms; Structure-Activity Relationship; Thiazoles; Thioacetamide; Urinary Bladder Neoplasms | 1973 |
Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Topics: Animals; Carcinogens; Carcinoma; Formamides; Hyperplasia; Male; Microscopy, Electron; Mitosis; Neoplasms, Experimental; Nitrofurans; Rats; Thiazoles; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms | 1973 |
Effect of the bladder carcinogen N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on nucleic acids and total protein content of bladder epithelium undergoing malignant change.
Topics: Animals; Autoradiography; Carcinogens; Cell Nucleus; Cytoplasm; DNA; Formamides; Leucine; Male; Microscopy, Electron; Nitrofurans; Protein Biosynthesis; Rats; RNA; Spectrophotometry; Thiazoles; Thymidine; Tritium; Uridine; Urinary Bladder; Urinary Bladder Neoplasms | 1974 |
The use of N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide in the study of bladder cancer.
Topics: Amides; Animals; Carcinogens; Disease Models, Animal; Formamides; Neoplasms, Experimental; Nitrofurans; Rats; Solvents; Thiazoles; Urinary Bladder Neoplasms | 1972 |
Pathogenesis, histology, and transplantability of urinary bladder carcinomas induced in albino rats by oral administration of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
Topics: Amides; Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Hyperplasia; Male; Neoplasm Transplantation; Nitrofurans; Rats; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1969 |
Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.
Topics: Amides; Animals; Female; Leukemia, Experimental; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Pregnancy; Thiazoles; Urinary Bladder Neoplasms; Uterine Neoplasms | 1970 |
Some sweetness left.
Topics: Academies and Institutes; Animals; Benzoates; Cyclamates; Foodborne Diseases; Lung Neoplasms; Mice; Neoplasms, Experimental; Rats; Saccharin; Sulfonamides; Sweetening Agents; Thiazoles; United States; Urinary Bladder Neoplasms | 1970 |
Production of urinary bladder carcinomas in mice by sodium saccharin.
Topics: Animals; Carcinoma, Squamous Cell; Cholesterol; Mice; Saccharin; Sweetening Agents; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1970 |